Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +46.47%
#2 Pons Pons +32.72%
#3 TENDIES TENDIES +30.34%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +29.71%
#5 Starpower Starpower +27.77%
#6 StonkBroker StonkBroker +24.40%
#7 Mubarak Mubarak +22.81%
#8 SkyAI SkyAI +21.73%
#9 PondCoin PondCoin +20.13%
#10 Decred Decred +19.43%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Sofiva Genomics Co.,Ltd. Sofiva Genomics Co.,Ltd.

Sofiva Genomics Co.,Ltd.

6615
Clasificación en acciones #29069
Sofiva Genomics Co.,Ltd., established in 2012 and based in Taipei, Taiwan,... Sofiva Genomics Co.,Ltd., established in 2012 and based in Taipei, Taiwan, offers a comprehensive range of genetic testing services to both domestic and international clients. The company's diverse diagnostic solutions are designed to support expectant parents, individuals with inherited conditions, and their families. Their extensive prenatal diagnostics include screenings for conditions such as thalassemia carrier status, various microdeletion syndromes, single-gene abnormalities, common chromosomal anomalies, and specific skeletal dysplasia mutations. They also provide multi-gene panel testing for inherited diseases, folate metabolism genetic analysis, carrier screening for spinal muscular atrophy (SMA) and Fragile X syndrome, congenital infection detection, preeclampsia risk assessment, maternal serum screening for Down syndrome, and karyotyping. Within the oncology sector, Sofiva Genomics delivers advanced cancer screenings, dynamic monitoring of tumor activity, and genetic evaluations for hereditary cancer predisposition. This includes specialized panels for women's cancers (breast, colon, ovarian, and endometrial), alongside human papillomavirus (HPV) screening. Furthermore, the company conducts genetic testing for rare diseases and provides specialized reproductive services such as preimplantation genetic diagnosis (PGD) and next-generation sequencing (NGS)-based preimplantation genetic screening (PGS). For newborns, their services encompass comprehensive "baby scans," screenings for hereditary sensorineural hearing loss, congenital central hypoventilation syndrome (CCHS), congenital cytomegalovirus (CMV) infection, and genetic risk assessment for atopic dermatitis. Beyond these specialized offerings, Sofiva Genomics also performs biochemical and chromosomal analyses, complemented by valuable advisory and support services for its clientele.
Precio por acción
$1.07
Capitalización bursátil
$23.11M
Cambio (1 día)
0.00%
Cambio (1 año)
4.66%
País
TW
Comercio Sofiva Genomics Co.,Ltd. (6615)

Categoría

Healthcare
Historial del precio de la acción de Sofiva Genomics Co.,Ltd. (6615)
Precio más alto de cierre: $1.08 el 2026-08-01

Precio más bajo de cierre: $2.57 el 2017-01-01
Historial del precio de la acción de Sofiva Genomics Co.,Ltd. desde 2017 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 7.82%
2025 -22.63%
2024 -2.51%
2023 6.01%
2022 -30.63%
2021 -8.66%
2020 -20.78%
2019 -15.38%
2018 -4.12%
2017 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 $615.22 23.47%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 $211.45 -0.35%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 $23.77 89.12%
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 $323.09 101.78%
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 $566.23 -11.07%
US